GlassScriptPhysician profile
Harry D Vildibill
NPI 1194702290
$3,822.68
in general payments reported to CMS, 2019-2025
29 companies · $238 in 2025
The $238 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.55 · 2020: $846 · 2021: $211 · 2022: $2,095 · 2023: $203 · 2024: $169 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,874.46 | 2022 | |
| W. L. Gore & Associates, INC. | $805.04 | 2020-2024 | Gore Synecor Biomaterial |
| Allergan, INC. | $108.59 | 2020-2022 | |
| Organogenesis INC. | $103.33 | 2020-2023 | Puraply |
| Medtronic, INC. | $83.59 | 2025 | Symbotex, Sonicision |
| Medical Device Business Services, INC. | $81.41 | 2024 | Harmonic |
| Kerecis Limited | $81.23 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Merck Sharp & Dohme LLC | $76.92 | 2022-2025 | Lynparza, Keytruda |
| Davol INC. | $73.87 | 2021-2022 | |
| Baxter Healthcare | $70.09 | 2022 | |
| Olympus America INC. | $48.07 | 2019-2020 | |
| Becton, Dickinson and Company | $44.48 | 2023-2024 | Phasix Mesh |
| Inspire Medical Systems, INC. | $39.00 | 2025 | Inspire |
| Polynovo North America LLC | $38.74 | 2023 | |
| Heron Therapeutics, INC. | $34.08 | 2021-2024 | Aponvie |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $27.13 | 2025 | Libtayo |
| Tela Bio, INC. | $26.64 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Hologic Sales and Service, LLC | $23.94 | 2023 | Trunode, Localizer, Trident Specimen Radiography System |
| Kci USA, INC. | $23.78 | 2023 | V.A.C.Instill, Prevena |
| Pacira Pharmaceuticals Incorporated | $22.05 | 2024 | Exparel |
| Csl Behring | $19.56 | 2022 | |
| Misonix INC | $18.59 | 2021 | |
| Ferring Pharmaceuticals INC. | $17.34 | 2019 | |
| Mallinckrodt Enterprises LLC | $16.26 | 2019 | |
| Innocoll Pharmaceuticals Limited | $13.96 | 2022 | |
| Smith+Nephew, INC. | $13.48 | 2023 | Collagenase Santyl, Regranex |
| Medline Industries LP | $13.35 | 2019 | |
| Abbvie INC. | $12.56 | 2022 | |
| Thd America, INC. | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Vildibill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.